New blinded preliminary safety and efficacy data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in podium presentation on ...
In-vivo CRO market size is projected to reach over USD 9 billion in revenue by the end of 2032. The demand for in vivo CROs ...